Fol. Biol. 2010, 56, 32-35
https://doi.org/10.14712/fb2010056010032
Circulating Endothelial Precursor Cells (EPC) in Patients Undergoing Allogeneic Haematopoietic Progenitor Cell Transplantation
References
1. 2002) Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359, 2078-2083.
< , B.C., Sahner, S., Gregor, M., Tsakiris, D. A., Jeanneret, C., Pober, J. S., Gratwohl, A. (https://doi.org/10.1016/S0140-6736(02)08907-9>
2. 1997) Soluble markers of endothelial cell function. Clin. Hemorheol. Microc. 17, 3-11.
, A., Seigneur, M. (
3. 2008) Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73, 186-193.
< , B., Dobos, J., Tovari, J., Paku, S., Kovacs, G., Ostoros, G., Timar, J. (https://doi.org/10.1002/cyto.a.20480>
4. 2009) Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia. Leuk. Lymphoma 50, 62-67.
< , J., Jamroziak, K., Szmigielska-Kaplon, A., Krawczynska, A., Lech-Maranda, E., Wierzbowska, A., Jesionek-Kupnicka, D., Blonski, J. Z., Robak, T. (https://doi.org/10.1080/10428190802549883>
5. 2005) Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111, 204-211.
< , J., Aletaha, D., Steiner, C. W., Kapral, T., Steiner, S., Seidinger, D., Weigel, G., Schwarzinger, I., Wolozcszuk, W., Steiner, G., Smolen, J. S. (https://doi.org/10.1161/01.CIR.0000151875.21836.AE>
6. 2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600.
< , J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., Finkel, T. (https://doi.org/10.1056/NEJMoa022287>
7. 2007) Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 92, 469-477.
< , C., Courinha, M., Cachaço, A. S., Pereira, T., Cabeçadas, J., da Silva, M. G., Dias, S. (https://doi.org/10.3324/haematol.10723>
8. 2008) Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation. Biol. Blood Marrow Transplant. 14, 766-774.
< , S., Ishii, K., Inami, N., Kimura, Y., Uoshima, N., Ishida, H., Yoshihara, T., Urase, F., Maeda, Y., Hayashi, K. (https://doi.org/10.1016/j.bbmt.2008.04.005>
9. 1998) Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann. Hematol. 76, 61-65.
, W., Michelmann, I., Burdach, S., Göbel, U. (
10. 1997) Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versushost disease. Bone Marrow Transplant. 19, 909-914.
< , C., Holler, E., Kolb, H. J., Pihusch, R., Reinhardt, B., Hiller, E. (https://doi.org/10.1038/sj.bmt.1700767>
11. 2007) Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110, 3463-3471.
< , A., Bucher, C., Rovó, A., Stussi, G., Stern, M., Paulussen, M., Halter, J., Meyer-Monard, S., Heim, D., Tsakiris, D. A., Biedermann, B., Passweg, J. R., Gratwohl, A. (https://doi.org/10.1182/blood-2006-10-054080>
12. 2004) CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110, 1209-1212.
< , M., Rigolin, G. M., Fucili, A., Porta, M. D., Soukhomovskaia, O., Malagutti, P., Bugli, A. M., Bragotti, L. Z., Francolini, G., Mauro, E., Castoldi, G., Ferrari, R. (https://doi.org/10.1161/01.CIR.0000136813.89036.21>
13. 2008) Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches. J. Immunol. Methods 332, 31-40.
< , E. M., Conraads, V. M., Van Bockstaele, D. R., Haine, S. E., Vermeulen, K., Van Tendeloo, V. F, Vrints, C. J., Hoymans, V. Y. (https://doi.org/10.1016/j.jim.2007.12.006>
14. 2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109, 2058-2067.
< , S., Kuliszewski, M. A., Li, S. H., Szmitko, P. E., Zucco, L., Wang, C. H., Badiwala, M. V., Mickle, D. A., Weisel, R. D., Fedak, P. W., Stewart, D. J., Kutryk, M. J. (https://doi.org/10.1161/01.CIR.0000127577.63323.24>
15. 2003) Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 41, 720-723.
< , A., Schroeder, M., Mengel, M., Schwarz, A., Gwinner, W., Haller, H., Haubitz, M. (https://doi.org/10.1161/01.HYP.0000052948.64125.AB>
16. 2004a) Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood 103, 3603-3605.
< , A., Scheer, J., Hambach, L., Buchholz, S., Ganser, A., Haller, H., Hertenstein, B., Haubitz, M. (https://doi.org/10.1182/blood-2003-10-3479>
17. 2004b) Counting the costs: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant. 34, 1015-1023.
< , A., Haubitz,M., Buchholz, S., Hertenstein, B (https://doi.org/10.1038/sj.bmt.1704733>
18. 2008) Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis. Kidney Blood Press Res. 31, 247-254.
< , J., Kideryová, L., Pytlík, R., Vanková, Z., Tesar, V. (https://doi.org/10.1159/000142690>